New targets of neuroprotection in ischemic stroke

TheScientificWorldJournal

Volumn 8, Issue , 2008, Pages 698-712

  Bacigaluppi, Marco ^a,b   Hermann, Dirk M ^a,c  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b SAN RAFFAELE HOSPITAL   (Italy)

^c UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Animal models; Neuroprotection; Neurorestoration; Pathophysiology; Reperfusion; Stroke

Indexed keywords

ERYTHROPOIETIN; ESTROGEN; GELATINASE B; GRANULOCYTE COLONY STIMULATING FACTOR; MELATONIN; MINOCYCLINE; MULTIDRUG RESISTANCE PROTEIN 1; NEUROPROTECTIVE AGENT; NOGO A ANTIBODY; OXYGEN; PROTEIN NOGO A; TISSUE PLASMINOGEN ACTIVATOR; VASCULOTROPIN;

ANALYSIS; BIOACCUMULATION; BRAIN ISCHEMIA; CELL THERAPY; CEREBROVASCULAR ACCIDENT; DISEASE MODEL; DRUG EFFICACY; EXPERIMENTAL STUDY; HUMAN; NEUROPROTECTION; NONHUMAN; PATHOPHYSIOLOGY; REVIEW;

ANIMALS; BRAIN ISCHEMIA; CELL TRANSPLANTATION; DISEASE MODELS, ANIMAL; HUMANS; NEUROPROTECTIVE AGENTS; STROKE;

ANIMALIA;

EID: 47349088595     PISSN: None     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1100/tsw.2008.94     Document Type: Review

References (146)

1. Garber, K. (2007) Stroke treatment - light at the end of the tunnel? Nat. Biotechnol. 25, 838-840.
2. (1999) Recommendations for standards regarding preclinical neuroprotective and restorative drug development. Stroke 30, 2752-2758.
3. Broderick, J.P. and Hacke, W. (2002) Treatment of acute ischemic stroke: Part I: recanalization strategies. Circulation 106, 1563-1569.
4. Savitz, S.I. and Fisher, M. (2007) Future of neuroprotection for acute stroke: in the aftermath of the SAINT trials. Ann. Neurol. 61, 396-402.
5. Hermann, D.M. and Bassetti, C.L. (2007) Neuroprotection in the SAINT-II aftermath. Ann. Neurol. 62(6), 677-678; author reply 678.
6. Hermann, D.M. and Bassetti, C.L. (2007) Implications of ATP-binding cassette transporters for brain pharmacotherapies. Trends Pharmacol. Sci. 28, 128-134.
7. Victor, M., Ropper, A.H., and Adams, R.D. (2001) Principles of Neurology. McGraw-Hill, New York.
8. Dirnagl, U., Iadecola, C., and Moskowitz, M.A. (1999) Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci. 22, 391-397.
9. Hossmann, K.A. (2006) Pathophysiology and therapy of experimental stroke. Cell. Mol. Neurobiol. 26, 1057-1083.
10. Hata, R., Maeda, K., Hermann, D., Mies, G., and Hossmann, K.A. (2000) Evolution of brain infarction after transient focal cerebral ischemia in mice. J. Cereb. Blood Flow Metab. 20, 937-946.
11. Hata, R., Maeda, K., Hermann, D., Mies, G., and Hossmann, K.A. (2000) Dynamics of regional brain metabolism and gene expression after middle cerebral artery occlusion in mice. J. Cereb. Blood Flow Metab. 20, 306-315.
12. Mies, G., Ishimaru, S., Xie, Y., Seo, K., and Hossmann, K.A. (1991) Ischemic thresholds of cerebral protein synthesis and energy state following middle cerebral artery occlusion in rat. J. Cereb. Blood Flow Metab. 11, 753-761.
13. Symon, L., Branston, N.M., Strong, A.J., and Hope, T.D. (1977) The concepts of thresholds of ischaemia in relation to brain structure and function. J. Clin. Pathol. Suppl. (R. Coll. Pathol.) 11, 149-154.
14. Wieloch, T. and Nikolich, K. (2006) Mechanisms of neural plasticity following brain injury. Curr. Opin. Neurobiol. 16, 258-264.
15. Harel, N.Y. and Strittmatter, S.M. (2006) Can regenerating axons recapitulate developmental guidance during recovery from spinal cord injury? Nat. Rev. 7, 603-616.
16. Bonilla, I.E., Tanabe, K., and Strittmatter, S.M. (2002) Small proline-rich repeat protein 1A is expressed by axotomized neurons and promotes axonal outgrowth. J. Neurosci. 22, 1303-1315.
17. Romanic, A.M., White, R.F., Arleth, A.J., Ohlstein, E.H., and Barone, F.C. (1998) Matrix metalloproteinase expression increases after cerebral focal ischemia in rats: inhibition of matrix metalloproteinase-9 reduces infarct size. Stroke 29, 1020-1030.
18. Asahi, M., Asahi, K., Jung, J.C., del Zoppo, G.J., Fini, M.E., and Lo, E.H. (2000) Role for matrix metalloproteinase 9 after focal cerebral ischemia: effects of gene knockout and enzyme inhibition with BB-94. J. Cereb. Blood Flow Metab. 20, 1681-1689.
19. Zhao, B.Q., Wang, S., Kim, H.Y., Storrie, H., Rosen, B.R., Mooney, D.J., Wang, X., and Lo, E.H. (2006) Role of matrix metalloproteinases in delayed cortical responses after stroke. Nat. Med. 12, 441-445.
20. Lo, E.H. (2008) A new penumbra: transitioning from injury into repair after stroke. Nat. Med. 14, 497-500.
21. Carmichael, S.T. (2005) Rodent models of focal stroke: size, mechanism, and purpose. NeuroRx 2, 396-409.
22. Menzies, S.A., Hoff, J.T., and Betz, A.L. (1992) Middle cerebral artery occlusion in rats: a neurological and pathological evaluation of a reproducible model. Neurosurgery 31, 100-106; discussion 106-107.
23. Namura, S., Zhu, J., Fink, K., Endres, M., Srinivasan, A., Tomaselli, K.J., Yuan, J., and Moskowitz, M.A. (1998) Activation and cleavage of caspase-3 in apoptosis induced by experimental cerebral ischemia. J. Neurosci. 18, 3659-3668.
24. Hermann, D.M., Kilic, E., Hata, R., Hossmann, K.A., and Mies, G. (2001) Relationship between metabolic dysfunctions, gene responses and delayed cell death after mild focal cerebral ischemia in mice. Neuroscience 104, 947-955.
25. Iadecola, C., Zhang, F., Casey, R., Nagayama, M., and Ross, M.E. (1997) Delayed reduction of ischemic brain injury and neurological deficits in mice lacking the inducible nitric oxide synthase gene. J. Neurosci. 17, 9157-9164.
26. Buchan, A.M., Xue, D., and Slivka, A. (1992) A new model of temporary focal neocortical ischemia in the rat. Stroke 23, 273-279.
27. Watson, B.D., Dietrich, W.D., Busto, R., Wachtel, M.S., and Ginsberg, M.D. (1985) Induction of reproducible brain infarction by photochemically initiated thrombosis. Ann. Neurol. 17, 497-504.
28. Gerriets, T., Li, F., Silva, M.D., Meng, X., Brevard, M., Sotak, C.H., and Fisher, M. (2003) The macrosphere model: evaluation of a new stroke model for permanent middle cerebral artery occlusion in rats. J. Neurosci. Methods 122, 201-211.
29. Miyake, K., Takeo, S., and Kaijihara, H. (1993) Sustained decrease in brain regional blood flow after microsphere embolism in rats. Stroke 24, 415-420.
30. Kilic, E., Hermann, D.M., and Hossmann, K.A. (1998) A reproducible model of thromboembolic stroke in mice. Neuroreport 9, 2967-2970.
31. Kilic, E., Hermann, D.M., and Hossmann, K.A. (1999) Recombinant tissue plasminogen activator reduces infarct size after reversible thread occlusion of middle cerebral artery in mice. Neuroreport 10, 107-111.
32. Brinker, G., Franke, C., Hoehn, M., Uhlenkuken, U., and Hossmann, K.A. (1999) Thrombolysis of cerebral clot embolism in rat: effect of treatment delay. Neuroreport 10, 3269-3272.
33. Brinker, G., Pillekamp, F., and Hossmann, K.A. (1999) Brain hemorrhages after rt-PA treatment of embolic stroke in spontaneously hypertensive rats. Neuroreport 10, 1943-1946.
34. Busch, E., Kruger, K., Allegrini, P.R., Kerskens, C.M., Gyngell, M.L., Hoehn-Berlage, M., and Hossmann, K.A. (1998) Reperfusion after thrombolytic therapy of embolic stroke in the rat: magnetic resonance and biochemical imaging. J. Cereb. Blood Flow Metab. 18, 407-418.
35. Kilic, E., Hermann, D.M., and Hossmann, K.A. (2000) Recombinant tissue-plasminogen activator-induced thrombolysis after cerebral thromboembolism in mice. Acta Neuropathol. 99, 219-222.
36. Hara, T., Mies, G., and Hossmann, K.A. (2000) Effect of thrombolysis on the dynamics of infarct evolution after clot embolism of middle cerebral artery in mice. J. Cereb. Blood Flow Metab. 20, 1483-1491.
37. (1995) Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N. Engl. J. Med. 333, 1581-1587.
38. Schellinger, P.D., Kaste, M., and Hacke, W. (2004) An update on thrombolytic therapy for acute stroke. Curr. Opin. Neurol. 17, 69-77.
39. Kulkens, S. and Hacke, W. (2007) Thrombolysis with alteplase for acute ischemic stroke: review of SITS-MOST and other Phase IV studies. Expert Rev. Neurother. 7, 783-788.
40. Hack, W., Kaste, M., Bogousslavsky, J., Brainin, M., Chamorro, A., Lees, K., Leys, D., Kwiecinski, H., Toni, P., Langhorne, P., Diener, C., Hennerici, M., Ferro, J., Sivenius, J., Gunnar, N., Bath, P., Olsen, T.S., and Gugging, M. (2003) European Stroke Initiative Recommendations for Stroke Management-update 2003. Cerebrovasc. Dis. 16, 311-337.
41. Hermann, D.M. and Matter, C.M. (2007) Tissue plasminogen activator-induced reperfusion injury after stroke revisited. Circulation 116, 363-365.
42. Wang, Y.F., Tsirka, S.E., Strickland, S., Stieg, P.E., Soriano, S.G., and Lipton, S.A. (1998) Tissue plasminogen activator (tPA) increases neuronal damage after focal cerebral ischemia in wild-type and tPA-deficient mice. Nat. Med. 4, 228-231.
43. Lopez-Atalaya, J.P., Roussel, B.D., Levrat, D., Parcq, J., Nicole, O., Hommet, Y., Benchenane, K., Castel, H., Leprince, J., To Van, D., Bureau, R., Rault, S., Vaudry, H., Petersen, K.U., Santos, J.S., Ali, C., and Vivien, D. (2008) Toward safer thrombolytic agents in stroke: molecular requirements for NMDA receptor-mediated neurotoxicity. J. Cereb. Blood Flow Metab. 28, 1212-1221.
44. Kilic, E., Kilic, U., Matter, C.M., Luscher, T.F., Bassetti, C.L., and Hermann, D.M. (2005) Aggravation of focal cerebral ischemia by tissue plasminogen activator is reversed by 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor but does not depend on endothelial NO synthase. Stroke 36, 332-336.
45. Zhang, L., Zhang, Z.G., Ding, G.L., Jiang, Q., Liu, X., Meng, H., Hozeska, A., Zhang, C., Li, L., Morris, D., Zhang, R.L., Lu, M., and Chopp, M. (2005) Multitargeted effects of statin-enhanced thrombolytic therapy for stroke with recombinant human tissue-type plasminogen activator in the rat. Circulation 112, 3486-3494.
46. Fisher, M. (1997) Characterizing the target of acute stroke therapy. Stroke 28, 866-872.
47. Back, T., Hoehn, M., Mies, G., Busch, E., Schmitz, B., Kohno, K., and Hossmann, K.A. (2000) Penumbral tissue alkalosis in focal cerebral ischemia: relationship to energy metabolism, blood flow, and steady potential. Ann. Neurol. 47, 485-492.
48. Mies, G., Kohno, K., and Hossmann, K.A. (1994) Prevention of periinfarct direct current shifts with glutamate antagonist NBQX following occlusion of the middle cerebral artery in the rat. J. Cereb. Blood Flow Metab. 14, 802-807.
49. Fisher, M. and Ratan, R. (2003) New perspectives on developing acute stroke therapy. Ann. Neurol. 53, 10-20.
50. (2006) Neuroprotection: the end of an era? Lancet 368, 1548.
51. O'Collins, V.E., Macleod, M.R., Donnan, G.A., Horky, L.L., van der Worp, B.H., and Howells, D.W. (2006) 1,026 experimental treatments in acute stroke. Ann. Neurol. 59, 467-477.
52. Alvarez-Buylla, A. and Lim, D.A. (2004) For the long run: maintaining germinal niches in the adult brain. Neuron 41, 683-686.
53. Ohab, J.J., Fleming, S., Blesch, A., and Carmichael, S.T. (2006) A neurovascular niche for neurogenesis after stroke. J. Neurosci. 26, 13007-13016.
54. Skaper, S.D., Floreani, M., Ceccon, M., Facci, L., and Giusti, P. (1999) Excitotoxicity, oxidative stress, and the neuroprotective potential of melatonin. Ann. N. Y. Acad. Sci. 890, 107-118.
55. Kilic, E., Kilic, U., Bacigaluppi, M., Guo, Z., Abdallah, N.B., Wolfer, D.P., Reiter, R.J., Hermann, D.M., and Bassetti, C.L. (2008) Delayed melatonin administration promotes neuronal survival, neurogenesis and motor recovery, and attenuates hyperactivity and anxiety after mild focal cerebral ischemia in mice. J. Pineal Res. [Epub ahead of print]
56. Skaper, S.D., Ancona, B., Facci, L., Franceschini, D., and Giusti, P. (1998) Melatonin prevents the delayed death of hippocampal neurons induced by enhanced excitatory neurotransmission and the nitridergic pathway. FASEB J. 12, 725-731.
57. Kilic, U., Kilic, E., Reiter, R.J., Bassetti, C.L., and Hermann, D.M. (2005) Signal transduction pathways involved in melatonin-induced neuroprotection after focal cerebral ischemia in mice. J. Pineal Res. 38, 67-71.
58. Chen, J. and Chopp, M. (2006) Neurorestorative treatment of stroke: cell and pharmacological approaches. NeuroRx 3, 466-473.
59. Carmichael, S.T. (2006) Cellular and molecular mechanisms of neural repair after stroke: making waves. Ann. Neurol. 59, 735-742.
60. Payne, B.R. and Lomber, S.G. (2001) Reconstructing functional systems after lesions of cerebral cortex. Nat. Rev. 2, 911-919.
61. Yiu, G. and He, Z. (2006) Glial inhibition of CNS axon regeneration. Nat. Rev. 7, 617-627.
62. Oudega, M., Rosano, C., Sadi, D., Wood, P.M., Schwab, M.E., and Hagg, T. (2000) Neutralizing antibodies against neurite growth inhibitor NI-35/250 do not promote regeneration of sensory axons in the adult rat spinal cord. Neuroscience 100, 873-883.
63. Fournier, A.E., GrandPre, T., and Strittmatter, S.M. (2001) Identification of a receptor mediating Nogo-66 inhibition of axonal regeneration. Nature 409, 341-346.
64. Mingorance, A., Fontana, X., Sole, M., Burgaya, F., Urena, J.M., Teng, F.Y., Tang, B.L., Hunt, D., Anderson, P.N., Bethea, J.R., Schwab, M.E., Soriano, E., and del Rio, J.A. (2004) Regulation of Nogo and Nogo receptor during the development of the entorhino-hippocampal pathway and after adult hippocampal lesions. Mol. Cell. Neurosci. 26, 34-49.
65. Chen, M.S., Huber, A.B., van der Haar, M.E., Frank, M., Schnell, L., Spillmann, A.A., Christ, F., and Schwab, M.E. (2000) Nogo-A is a myelin-associated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN-1. Nature 403, 434-439.
66. Kartje, G.L., Schulz, M.K., Lopez-Yunez, A., Schnell, L., and Schwab, M.E. (1999) Corticostriatal plasticity is restricted by myelin-associated neurite growth inhibitors in the adult rat. Ann. Neurol. 45, 778-786.
67. Bareyre, F.M., Kerschensteiner, M., Raineteau, O., Mettenleiter, T.C., Weinmann, O., and Schwab, M.E. (2004) The injured spinal cord spontaneously forms a new intraspinal circuit in adult rats. Nat. Neurosci. 7, 269-277.
68. Markus, T.M., Tsai, S.Y., Bollnow, M.R., Farrer, R.G., O'Brien, T.E., Kindler-Baumann, D.R., Rausch, M., Rudin, M., Wiessner, C., Mir, A.K., Schwab, M.E., and Kartje, G.L. (2005) Recovery and brain reorganization after stroke in adult and aged rats. Ann. Neurol. 58, 950-953.
69. Bacigaluppi, M., Pluchino, S., Martino, G., Kilic, E., and Hermann, D.M. (2007) Neural stem/precursor cells for the treatment of ischemic stroke. J. Neurol. Sci. 265(1-2), 73-77.
70. Bliss, T., Guzman, R., Daadi, M., and Steinberg, G.K. (2007) Cell transplantation therapy for stroke. Stroke 38, 817-826.
71. Abbott, N.J., Ronnback, L., and Hansson, E. (2006) Astrocyte-endothelial interactions at the blood-brain barrier. Nat. Rev. 7, 41-53.
72. Kilic, E., Kilic, U., and Hermann, D.M. (2005) TAT-GDNF in neurodegeneration and ischemic stroke. CNS Drug Rev. 11, 369-378.
73. Begley, D.J. (2004) Delivery of therapeutic agents to the central nervous system: the problems and the possibilities. Pharmacol. Ther. 104, 29-45.
74. Loscher, W. and Potschka, H. (2005) Drug resistance in brain diseases and the role of drug efflux transporters. Nat. Rev. 6, 591-602.
75. Higgins, C.F. and Linton, K.J. (2004) The ATP switch model for ABC transporters. Nat. Struct. Mol. Biol. 11, 918-926.
76. Gottesman, M.M., Fojo, T., and Bates, S.E. (2002) Multidrug resistance in cancer: role of ATP-dependent transporters. Nat. Rev. Cancer 2, 48-58.
77. Abbott, N.J., Khan, E.U., Rollinson, C.M., Reichel, A., Janigro, D., Dombrowski, S.M., Dobbie, M.S., and Begley, D.J. (2002) Drug resistance in epilepsy: the role of the blood-brain barrier. Novartis Found. Symp. 243, 38-47; discussion 47-53, 180-185.
78. Spudich, A., Kilic, E., Xing, H., Kilic, U., Rentsch, K.M., Wunderli-Allenspach, H., Bassetti, C.L., and Hermann, D.M. (2006) Inhibition of multidrug resistance transporter-1 facilitates neuroprotective therapies after focal cerebral ischemia. Nat. Neurosci. 9, 487-488.
79. Soontornmalai, A., Vlaming, M.L., and Fritschy, J.M. (2006) Differential, strain-specific cellular and subcellular distribution of multidrug transporters in murine choroid plexus and blood-brain barrier. Neuroscience 138, 159-169.
80. Tsai, S.Y., Markus, T.M., Andrews, E.M., Cheatwood, J.L., Emerick, A.J., Mir, A.K., Schwab, M.E., and Kartje, G.L. (2007) Intrathecal treatment with anti-Nogo-A antibody improves functional recovery in adult rats after stroke. Exp. Brain Res. 182, 261-266.
81. Freund, P., Schmidlin, E., Wannier, T., Bloch, J., Mir, A., Schwab, M.E., and Rouiller, E.M. (2006) Nogo-A-specific antibody treatment enhances sprouting and functional recovery after cervical lesion in adult primates. Nat. Med. 12, 790-792.
82. Robin, A.M., Zhang, Z.G., Wang, L., Zhang, R.L., Katakowski, M., Zhang, L., Wang, Y., Zhang, C., and Chopp, M. (2006) Stromal cell-derived factor 1alpha mediates neural progenitor cell motility after focal cerebral ischemia. J. Cereb. Blood Flow Metab. 26, 125-134.
83. Thored, P., Wood, J., Arvidsson, A., Cammenga, J., Kokaia, Z., and Lindvall, O. (2007) Long-term neuroblast migration along blood vessels in an area with transient angiogenesis and increased vascularization after stroke. Stroke 38, 3032-3039.
84. Zhang, R.L., LeTourneau, Y., Gregg, S.R., Wang, Y., Toh, Y., Robin, A.M., Zhang, Z.G., and Chopp, M. (2007) Neuroblast division during migration toward the ischemic striatum: a study of dynamic migratory and proliferative characteristics of neuroblasts from the subventricular zone. J. Neurosci. 27, 3157-3162.
85. Pluchino, S., Zanotti, L., Rossi, B., Brambilla, E., Ottoboni, L., Salani, G., Martinello, M., Cattalini, A., Bergami, A., Furlan, R., Comi, G., Constantin, G., and Martino, G. (2005) Neurosphere-derived multipotent precursors promote neuroprotection by an immunomodulatory mechanism. Nature 436, 266-271.
86. Andrews, E.M., Tsai, S.Y., Johnson, S.C., Farrer, J.R., Wagner, J.P., Kopen, G.C., and Kartje, G.L. (2008) Human adult bone marrow-derived somatic cell therapy results in functional recovery and axonal plasticity following stroke in the rat. Exp. Neurol. 211, 588-592.
87. Nemoto, E.M., Bleyaert, A.L., Stezoski, S.W., Moossy, J., Rao, G.R., and Safar, P. (1977) Global brain ischemia: a reproducible monkey model. Stroke 8, 558-564.
88. Bodsch, W., Barbier, A., Oehmichen, M., Grosse Ophoff, B., and Hossmann, K.A. (1986) Recovery of monkey brain after prolonged ischemia. II. Protein synthesis and morphological alterations. J. Cereb. Blood Flow Metab. 6, 22-33.
89. Symon, L. (1975) Experimental model of stroke in the baboon. Adv. Neurol. 10, 199-212.
90. Yonas, H., Wolfson, S.K., Jr., Dujovny, M., Boehnke, M., and Cook, E. (1981) Selective lenticulostriate occlusion in the primate. A highly focal cerebral ischemia model. Stroke 12, 567-572.
91. Hudgins, W.R. and Garcia, J.H. (1970) Transorbital approach to the middle cerebral artery of the squirrel monkey: a technique for experimental cerebral infarction applicable to ultrastructural studies. Stroke 1, 107-111.
92. Liu, X.G., Branston, N.M., Kawauchi, M., and Symon, L. (1992) A model of acute focal ischemia in the territory of the anterior cerebral artery in baboons. Stroke 23, 40-44.
93. Radovsky, A., Safar, P., Sterz, F., Leonov, Y., Reich, H., and Kuboyama, K. (1995) Regional prevalence and distribution of ischemic neurons in dog brains 96 hours after cardiac arrest of 0 to 20 minutes. Stroke 26, 2127-2133; discussion 2133-2124.
94. Pomfy, M. and Franko, J. (1999) Validation of a four-vessel occlusion model for transient global cerebral ischemia in dogs. J. Hirnforsch. 39, 465-471.
95. Purdy, P.D., Devous, M.D., Sr., Batjer, H.H., White, C.L., 3rd, Meyer, Y., and Samson, D.S. (1989) Microfibrillar collagen model of canine cerebral infarction. Stroke 20, 1361-1367.
96. Purdy, P.D., Devous, M.D., Sr., White, C.L., 3rd, Batjer, H.H., Samson, D.S., Brewer, K., and Hodges, K. (1989) Reversible middle cerebral artery embolization in dogs without intracranial surgery. Stroke 20, 1368-1376.
97. Kuwabara, S., Uno, J., and Ishikawa, S. (1988) A new model of brainstem ischemia in dogs. Stroke 19, 365-371.
98. Chopp, M., Frinak, S., Walton, D.R., Smith, M.B., and Welch, K.M. (1987) Intracellular acidosis during and after cerebral ischemia: in vivo nuclear magnetic resonance study of hyperglycemia in cats. Stroke 18, 919-923.
99. Hossmann, K.A. and Sato, K. (1970) The effect of ischemia on sensorimotor cortex of cat. Electrophysiological, biochemical and electronmicroscopial observations. Z. Neurol. 198, 33-45.
100. O'Brien, M.D. and Waltz, A.G. (1973) Transorbital approach for occluding the middle cerebral artery without craniectomy. Stroke 4, 201-206.
101. Shigeno, S., Fritschka, E., Shigeno, T., and Brock, M. (1985) Effects of indomethacin on rCBF during and after focal cerebral ischemia in the cat. Stroke 16, 235-240.
102. Berkowitz, I.D., Gervais, H., Schleien, C.L., Koehler, R.C., Dean, J.M., and Traystman, R.J. (1991) Epinephrine dosage effects on cerebral and myocardial blood flow in an infant swine model of cardiopulmonary resuscitation. Anesthesiology 75, 1041-1050.
103. Sakoh, M., Rohl, L., Gyldensted, C., Gjedde, A., and Ostergaard, L. (2000) Cerebral blood flow and blood volume measured by magnetic resonance imaging bolus tracking after acute stroke in pigs: comparison with [(15)O]H(2)O positron emission tomography. Stroke 31, 1958-1964.
104. Kirino, T. (1982) Delayed neuronal death in the gerbil hippocampus following ischemia. Brain Res. 239, 57-69.
105. Levine, S. and Payan, H. (1966) Effects of ischemia and other procedures on the brain and retina of the gerbil (Meriones unguiculatus). Exp. Neurol. 16, 255-262.
106. Lapchak, P.A., Araujo, D.M., Pakola, S., Song, D., Wei, J., and Zivin, J.A. (2002) Microplasmin: a novel thrombolytic that improves behavioral outcome after embolic strokes in rabbits. Stroke 33, 2279-2284.
107. Gjedde, A. and Siemkowicz, E. (1978) Effect of glucose and insulin pretreatment on cerebral metabolic recovery after ischemia. Trans. Am. Neurol. Assoc. 103, 45-47.
108. Bottiger, B.W., Popp, E., and Teschendorf, P. (2007) A new model of cardiac arrest in rats? Resuscitation 76(2), 317-318.
109. Fujimura, M., Morita-Fujimura, Y., Murakami, K., Kawase, M., and Chan, P.H. (1998) Cytosolic redistribution of cytochrome c after transient focal cerebral ischemia in rats. J. Cereb. Blood Flow Metab. 18, 1239-1247.
110. Pulsinelli, W.A. and Brierley, J.B. (1979) A new model of bilateral hemispheric ischemia in the unanesthetized rat. Stroke 10, 267-272.
111. Eklof, B. and Siesjo, B.K. (1972) The effect of bilateral carotid artery ligation upon acid-base parameters and substrate levels in the rat brain. Acta Physiol. Scand. 86, 528-538.
112. Memezawa, H., Smith, M.L., and Siesjo, B.K. (1992) Penumbral tissues salvaged by reperfusion following middle cerebral artery occlusion in rats. Stroke 23, 552-559.
113. Schmid-Elsaesser, R., Zausinger, S., Hungerhuber, E., Baethmann, A., and Reulen, H.J. (1998) A critical reevaluation of the intraluminal thread model of focal cerebral ischemia: evidence of inadvertent premature reperfusion and subarachnoid hemorrhage in rats by laser-Doppler flowmetry. Stroke 29, 2162-2170.
114. Tamura, A., Graham, D.I., McCulloch, J., and Teasdale, G.M. (1981) Focal cerebral ischaemia in the rat: 1. Description of technique and early neuropathological consequences following middle cerebral artery occlusion. J. Cereb. Blood Flow Metab. 1, 53-60.
115. Brint, S., Jacewicz, M., Kiessling, M., Tanabe, J., and Pulsinelli, W. (1988) Focal brain ischemia in the rat: methods for reproducible neocortical infarction using tandem occlusion of the distal middle cerebral and ipsilateral common carotid arteries. J. Cereb. Blood Flow Metab. 8, 474-485.
116. Chen, S.T., Hsu, C.Y., Hogan, E.L., Maricq, H., and Balentine, J.D. (1986) A model of focal ischemic stroke in the rat: reproducible extensive cortical infarction. Stroke 17, 738-743.
117. Dietrich, W.D., Busto, R., Watson, B.D., Scheinberg, P., and Ginsberg, M.D. (1987) Photochemically induced cerebral infarction. II. Edema and blood-brain barrier disruption. Acta Neuropathol. 72, 326-334.
118. Wang, C.X., Todd, K.G., Yang, Y., Gordon, T., and Shuaib, A. (2001) Patency of cerebral microvessels after focal embolic stroke in the rat. J. Cereb. Blood Flow Metab. 21, 413-421.
119. Garcia-Segura, L.M., Azcoitia, I., and DonCarlos, L.L. (2001) Neuroprotection by estradiol. Prog. Neurobiol. 63, 29-60.
120. Green, P.S. and Simpkins, J.W. (2000) Neuroprotective effects of estrogens: potential mechanisms of action. Int. J. Dev. Neurosci. 18, 347-358.
121. Dubal, D.B., Kashon, M.L., Pettigrew, L.C., Ren, J.M., Finklestein, S.P., Rau, S.W., and Wise, P.M. (1998) Estradiol protects against ischemic injury. J. Cereb. Blood Flow Metab. 18, 1253-1258.
122. Culmsee, C., Vedder, H., Ravati, A., Junker, V., Otto, D., Ahlemeyer, B., Krieg, J.C., and Krieglstein, J. (1999) Neuroprotection by estrogens in a mouse model of focal cerebral ischemia and in cultured neurons: evidence for a receptor-independent antioxidative mechanism. J. Cereb. Blood Flow Metab. 19, 1263-1269.
123. Arvin, K.L., Han, B.H., Du, Y., Lin, S.Z., Paul, S.M., and Holtzman, D.M. (2002) Minocycline markedly protects the neonatal brain against hypoxic-ischemic injury. Ann. Neurol. 52, 54-61.
124. Stirling, D.P., Khodarahmi, K., Liu, J., McPhail, L.T., McBride, C.B., Steeves, J.D., Ramer, M.S., and Tetzlaff, W. (2004) Minocycline treatment reduces delayed oligodendrocyte death, attenuates axonal dieback, and improves functional outcome after spinal cord injury. J. Neurosci. 24, 2182-2190.
125. Amin, A.R., Attur, M.G., Thakker, G.D., Patel, P.D., Vyas, P.R., Patel, R.N., Patel, I.R., and Abramson, S.B. (1996) A novel mechanism of action of tetracyclines: effects on nitric oxide synthases. Proc. Natl. Acad. Sci. U. S. A. 93, 14014-14019.
126. Lampl, Y., Boaz, M., Gilad, R., Lorberboym, M., Dabby, R., Rapoport, A., Anca-Hershkowitz, M., and Sadeh, M. (2007) Minocycline treatment in acute stroke: an open-label, evaluator-blinded study. Neurology 69, 1404-1410.
127. Teng, Y.D., Choi, H., Onario, R.C., Zhu, S., Desilets, F.C., Lan, S., Woodard, E.J., Snyder, E.Y., Eichler, M.E., and Friedlander, R.M. (2004) Minocycline inhibits contusion-triggered mitochondrial cytochrome c release and mitigates functional deficits after spinal cord injury. Proc. Natl. Acad. Sci. U. S. A. 101, 3071-3076.
128. Tikka, T.M. and Koistinaho, J.E. (2001) Minocycline provides neuroprotection against N-methyl-D-aspartate neurotoxicity by inhibiting microglia. J. Immunol. 166, 7527-7533.
129. Bernaudin, M., Marti, H.H., Roussel, S., Divoux, D., Nouvelot, A., MacKenzie, E.T., and Petit, E. (1999) A potential role for erythropoietin in focal permanent cerebral ischemia in mice. J. Cereb. Blood Flow Metab. 19, 643-651.
130. Digicaylioglu, M. and Lipton, S.A. (2001) Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-kappaB signalling cascades. Nature 412, 641-647.
131. Siren, A.L., Fratelli, M., Brines, M., Goemans, C., Casagrande, S., Lewczuk, P., Keenan, S., Gleiter, C., Pasquali, C., Capobianco, A., Mennini, T., Heumann, R., Cerami, A., Ehrenreich, H., and Ghezzi, P. (2001) Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress. Proc. Natl. Acad. Sci. U. S. A. 98, 4044-4049.
132. Villa, P., Bigini, P., Mennini, T., Agnello, D., Laragione, T., Cagnotto, A., Viviani, B., Marinovich, M., Cerami, A., Coleman, T.R., Brines, M., and Ghezzi, P. (2003) Erythropoietin selectively attenuates cytokine production and inflammation in cerebral ischemia by targeting neuronal apoptosis. J. Exp. Med. 198, 971-975.
133. Kilic, U., Kilic, E., Soliz, J., Bassetti, C.I., Gassmann, M., and Hermann, D.M. (2005) Erythropoietin protects from axotomy-induced degeneration of retinal ganglion cells by activating ERK-1/-2. FASEB J. 19, 249-251.
134. Kilic, E., Kilic, U., Soliz, J., Bassetti, C.L., Gassmann, M., and Hermann, D.M. (2005) Brain-derived erythropoietin protects from focal cerebral ischemia by dual activation of ERK-1/-2 and Akt pathways. FASEB J. 19, 2026-2028.
135. Sun, Y., Jin, K., Xie, L., Childs, J., Mao, X.O., Logvinova, A., and Greenberg, D.A. (2003) VEGF-induced neuroprotection, neurogenesis, and angiogenesis after focal cerebral ischemia. J. Clin. Invest. 111, 1843-1851.
136. Wang, Y., Kilic, E., Kilic, U., Weber, B., Bassetti, C.L., Marti, H.H., and Hermann, D.M. (2005) VEGF overexpression induces post-ischaemic neuroprotection, but facilitates haemodynamic steal phenomena. Brain 128, 52-63.
137. Zhang, Z.G., Zhang, L., Jiang, Q., Zhang, R., Davies, K., Powers, C., Bruggen, N., and Chopp, M. (2000) VEGF enhances angiogenesis and promotes blood-brain barrier leakage in the ischemic brain. J. Clin. Invest. 106, 829-838.
138. Sehara, Y., Hayashi, T., Deguchi, K., Zhang, H., Tsuchiya, A., Yamashita, T., Lukic, V., Nagai, M., Kamiya, T., and Abe, K. (2007) Decreased focal inflammatory response by G-CSF may improve stroke outcome after transient middle cerebral artery occlusion in rats. J. Neurosci. Res. 85, 2167-2174.
139. Schabitz, W.R., Kollmar, R., Schwaninger, M., Juettler, E., Bardutzky, J., Scholzke, M.N., Sommer, C., and Schwab, S. (2003) Neuroprotective effect of granulocyte colony-stimulating factor after focal cerebral ischemia. Stroke 34, 745-751.
140. Lu, C.Z. and Xiao, B.G. (2007) Neuroprotection of G-CSF in cerebral ischemia. Front. Biosci. 12, 2869-2875.
141. Lee, M.Y., Kuan, Y.H., Chen, H.Y., Chen, T.Y., Chen, S.T., Huang, C.C., Yang, I.P., Hsu, Y.S., Wu, T.S., and Lee, E.J. (2007) Intravenous administration of melatonin reduces the intracerebral cellular inflammatory response following transient focal cerebral ischemia in rats. J. Pineal Res. 42, 297-309.
142. Olsen, T.S., Weber, U.J., and Kammersgaard, L.P. (2003) Therapeutic hypothermia for acute stroke. Lancet Neurol. 2, 410-416.
143. Karibe, H., Zarow, G.J., Graham, S.H., and Weinstein, P.R. (1994) Mild intraischemic hypothermia reduces postischemic hyperperfusion, delayed postischemic hypoperfusion, blood-brain barrier disruption, brain edema, and neuronal damage volume after temporary focal cerebral ischemia in rats. J. Cereb. Blood Flow Metab. 14, 620-627.
144. Kammersgaard, L.P., Rasmussen, B.H., Jorgensen, H.S., Reith, J., Weber, U., and Olsen, T.S. (2000) Feasibility and safety of inducing modest hypothermia in awake patients with acute stroke through surface cooling: a case-control study: the Copenhagen Stroke Study. Stroke 31, 2251-2256.
145. Eschenfelder, C.C., Krug, R., Yusofi, A.F., Meyne, J.K., Herdegen, T., Koch, A., Zhao, Y., Carl, U.M., and Deuschl, G. (2008) Neuroprotection by oxygen in acute transient focal cerebral ischemia is dose dependent and shows superiority of hyperbaric oxygenation. Cerebrovasc. Dis. 25, 193-201.
146. Kim, H.Y., Singhal, A.B., and Lo, E.H. (2005) Normobaric hyperoxia extends the reperfusion window in focal cerebral ischemia. Ann. Neurol. 57, 571-575.